• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    185.22 Up 1.36(0.74%) 4:00PM EDT
    |After Hours : 185.22 0.00 (0.00%) 6:44PM EDT
    Add to Portfolio
    Prev Close:183.86
    Open:184.00
    Bid:184.11 x 100
    Ask:185.25 x 300
    1y Target Est:220.00
    Beta:1.44
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:183.18 - 185.25
    52wk Range:150.06 - 203.30
    Volume:1,501,802
    Avg Vol (3m):2,136,700
    Market Cap:41.51B
    P/E (ttm):63.45
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.74%41.51B
    AMGNDown 1.12%116.53B
    BAXDown 1.44%20.82B

    Key Statistics

    Forward P/E (1 yr):30.92
    P/S (ttm):16.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.98
    Quarterly EPS Est (Jun-15) :1.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback